Leuko Labs
PrivateLast Round
Grant
Jul 23, 2024
Total Funding Raised
$12.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Leuko Labs is a medical device company developing PointCheck, a non-invasive device that monitors white blood cell levels for cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leuko Labs Comparables
Compare Leuko Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RizLab Health | 81% | |
| Alacrity Care | 78% | |
| Entia | 77% |
Leuko Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 23, 2024 | ||||
| Series A | Sep 23, 2022 | ||||
| Seed | Jul 17, 2019 | ||||
| Grant | Jun 5, 2018 | ||||
| Accelerator | May 11, 2018 |
Key People
Founding team and executive leadership
Leuko Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Good Growth Capital | Series A, Seed |
| Nina Capital | Seed, Series A |
| IAG Capital Partners | Series A |
| NIH RADx | Grant |
| MassChallenge Israel | Grant |
| MIT Alumni Angels of Boston | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 52% MoM.
- Jul 17, 2026
Grew 19% QoQ, from 16 to 19 employees.
Leuko Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Leuko Labs's valuation, stock price, and market status.
Is Leuko Labs a public or private company?
Leuko Labs is a private company.
What is the current stock price of Leuko Labs?
Leuko Labs is a private company, so its shares have no public market price. Caplight tracks Leuko Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Leuko Labs worth (valuation)?
Valuation information for Leuko Labs is not publicly available.
Can I buy Leuko Labs stock?
Leuko Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Leuko Labs's last funding round?
Leuko Labs's most recent funding round was Grant on July 23, 2024.
Who are the main investors in Leuko Labs?
Key investors in Leuko Labs include Good Growth Capital, Health Technology Holding, Pegasus Tech Ventures.
Will Leuko Labs IPO soon?
No public IPO plans have been announced for Leuko Labs.
How can I track Leuko Labs secondary market activity?
Caplight tracks bids, offers, and trades in Leuko Labs's shares on secondary markets.